ZVRA
Zevra TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ZVRA vs peer average
55/100
ZVRA vs. peer average (C vs. C)
Grade spread
A 2 · C 2 · D 5 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ALT is the first available peer comparator.
Closest size-based biotech candidate in the packet, but its pipeline and indications are not directly comparable to Zevra's commercial rare-disease portfolio.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ZVRA
Zevra Therapeutics
ALT
Altimmune
Grade
C
D
Momentum
63
36
Value
67
41
Sentiment
52
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs ALT
ZVRA / ALT
Grade Position
In line
ZVRA vs. peer average (C vs. C)
55/100
Momentum
63
ZVRAValue
67
ZVRASentiment
52
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ZVRA
ALT is the first peer returned for this comparison set.